Recruiting Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin NCT05069688 Conditions Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +8 more Locations University College Hospital/ University of Ibadan — Ibadan, Oyo State, Nigeria View Trial Details
Recruiting Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention NCT06281834 Conditions Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +7 more Locations University College Hospital — Ibadan, Oyo State, Nigeria View Trial Details
Completed Evaluating the Feasibility of Point of Care Birth Testing in Eswatini NCT04206878 Conditions Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +18 more Locations Mbabane Government Hospital, Hlathikhulu Hospital, and Good Shepherd Hospital — Mbabane, Eswatini View Trial Details
Completed Impact of Point-of-Care EID for HIV-Exposed Infants NCT03824067 Conditions Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more Locations Elizabeth Glaser Pediatric AIDS Foundation — Nairobi, Kenya Elizabeth Glaser Pediatric AIDS Foundation — Harare, Zimbabwe View Trial Details
Completed Evaluating an HIV Risk Screening Tool for Orphans and Vulnerable Children in Tanzania NCT04517760 Conditions Pediatric HIV Infection Locations Elizabeth Glaser Pediatric AIDS Foundation — Dar es Salaam, Tanzania View Trial Details
